BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 18, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VX-770: Completed Phase III enrollment

Vertex completed enrollment of about 120 patients ages 12 and up carrying the G551D mutation in CFTR on at least 1 allele in the double-blind, placebo-controlled, international...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >